Business Description
Susmed Inc
ISIN : JP3319150003
Total Employee Number:
43Description
Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.97 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 73.29 | |||||
Beneish M-Score | -1.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.5 | |||||
3-Year EBITDA Growth Rate | -3.9 | |||||
3-Year EPS without NRI Growth Rate | -5.4 | |||||
3-Year FCF Growth Rate | -30.5 | |||||
3-Year Book Growth Rate | -4.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 82.97 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.18 | |||||
9-Day RSI | 61.97 | |||||
14-Day RSI | 58.29 | |||||
3-1 Month Momentum % | -41.42 | |||||
6-1 Month Momentum % | -26.78 | |||||
12-1 Month Momentum % | 2.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 35.29 | |||||
Quick Ratio | 35.29 | |||||
Cash Ratio | 34.61 | |||||
Days Inventory | 5.31 | |||||
Days Sales Outstanding | 18.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 94.48 | |||||
Operating Margin % | -180.63 | |||||
Net Margin % | -176.24 | |||||
EBITDA Margin % | -177.74 | |||||
FCF Margin % | -164.38 | |||||
OCF Margin % | -157.12 | |||||
ROE % | -11.32 | |||||
ROA % | -10.99 | |||||
ROIC % | -290.32 | |||||
3-Year ROIIC % | -101.49 | |||||
ROCE % | -11.59 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 17.89 | |||||
PS Ratio | 51.44 | |||||
PB Ratio | 3.45 | |||||
Price-to-Tangible-Book | 3.53 | |||||
EV-to-EBIT | -20.56 | |||||
EV-to-EBITDA | -20.9 | |||||
EV-to-Revenue | 37.14 | |||||
EV-to-FCF | -22.59 | |||||
Price-to-GF-Value | 0.86 | |||||
| Price-to-Net-Current-Asset-Value | 3.62 | |||||
| Price-to-Net-Cash | 3.69 | |||||
Earnings Yield (Greenblatt) % | -4.86 | |||||
FCF Yield % | -3.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Susmed Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 275.248 | ||
| EPS (TTM) (円) | -28.83 | ||
| Beta | 0.0167 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.28 | ||
| Volatility % | 63.82 | ||
| 14-Day RSI | 58.29 | ||
| 14-Day ATR (円) | 49.979785 | ||
| 20-Day SMA (円) | 766.35 | ||
| 12-1 Month Momentum % | 2.32 | ||
| 52-Week Range (円) | 587 - 1231 | ||
| Shares Outstanding (Mil) | 16.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Susmed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Susmed Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Susmed Inc Frequently Asked Questions
What is Susmed Inc(TSE:4263)'s stock price today?
The current price of TSE:4263 is 円841.00. The 52 week high of TSE:4263 is 円1231.00 and 52 week low is 円587.00.
When is next earnings date of Susmed Inc(TSE:4263)?
The next earnings date of Susmed Inc(TSE:4263) is .
Does Susmed Inc(TSE:4263) pay dividends? If so, how much?
Susmed Inc(TSE:4263) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Susmed Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers